This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry...
Background Dillard’s (NYSE:DDS) is one of the leading American upscale department stores offering fashion apparel, cosmetics and home furnishing through its 277 stores across...
Insurance stocks were majors winners last year. 2023 has brought about a big trend change, though. The SPDR S&P Insurance ETF (KIE) has underperformed...
Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on May 27th, 2023....
Much has been discussed in the media about whether Apple’s (NASDAQ:AAPL) newly-launched mixed reality or MR device could disrupt the market not just against...
The AI Investment Thesis Is Inevitably Robust With CrowdStrike CRWD 3Y Stock Price Trading View CrowdStrike Holdings (NASDAQ:CRWD) continues to ride the AI wave...
Introduction I am keen on investing in royalty companies focusing on acquiring and raking in the cash from pharmaceutical royalties. My position in DRI...